Prostate cancer decisions — 2025

The appeal for service connection of prostate cancer is remanded. The VA will verify the veteran's exposure to toxins and provide a new medical opinion.

The VA denied the veteran's appeal to restore his rating for prostate cancer from 60% to 100%. The VA found that the reduction was proper and that the criteria for a higher rating were not met.

The Veteran is granted a 40 percent disability rating for his service-connected residuals of prostate cancer, for the period on appeal prior to August 31, 2020.

The Board denied service connection for a skin rash, asthma, Alzheimer's disease, and prostate cancer as the evidence did not support a finding that these conditions began during active service or are otherwise related to an in-service injury, event, or disease.

The veteran's prostate cancer status post radical prostatectomy is granted a 40% disability rating effective June 1, 2024.

The Board denied the veteran's appeal for an effective date earlier than August 10, 2022, for service connection of prostate cancer, hypertension, diabetes mellitus type 2, arteriosclerotic heart disease, erectile dysfunction, and special monthly compensation (SMC) based on loss of use of creative organ.

The appeal for service connection of prostate cancer was dismissed because the VA already granted it under the PACT Act.

The Board remanded the veteran's claims for service connection for several conditions, including diabetes mellitus type II, heart disability, kidney disease with acute renal failure, hyperkalemia, prostate cancer, and blood clot in the left arm. The decision was based on a need to obtain private treatment records.

The Veteran's death from metastatic prostate cancer is service-connected due to asbestos exposure during his active duty. The Board granted service connection for the cause of death.

The Board has remanded the veteran's claims for service connection for an acquired psychiatric disorder, obstructive sleep apnea, and prostate cancer residuals due to new and relevant evidence. The veteran will undergo further examinations.

The Board remanded all issues to the VA for further evaluation, including toxic exposure risk activities.

The veteran's prostate cancer and bone cancer are service-connected. The prostate cancer is due to herbicide exposure in Vietnam, and the bone cancer is secondary to the prostate cancer.

The appeal regarding the rating reduction for service-connected prostate cancer with erectile dysfunction was dismissed because the veteran requested to withdraw the appeal.

The veteran's service-connected PTSD and prostate cancer have been determined to prevent him from obtaining or maintaining substantially gainful employment, so he has been granted a total disability rating based on individual unemployability (TDIU).

The Veteran's service connection for prostate cancer is granted due to presumptive herbicide exposure during his deployment to Udorn Royal Thai Air Force Base in 1972.

The veteran's claim for service connection for prostate cancer was granted. The claim for bilateral lung cancer residuals was remanded for further development.

The veteran's appeals for a higher rating and TDIU were dismissed because the veteran withdrew them.

The Board denied service connection for hypertension, residuals of prostate cancer, and residuals of a cervical lipoma. The evidence did not show that these conditions are related to the veteran's service.

The Board denied service connection for prostate cancer and diabetes mellitus, type II, due to lack of evidence linking these conditions to the veteran's military service.

The appeal regarding the proposed reduction in the rating for prostate cancer was dismissed because it was not a final action. The claim for service connection for bilateral hearing loss was denied due to lack of evidence linking it to military service.